Clinical Trial Update: Depiction of Delayed Enhancement in Patients With Documented Myocardial Infarction [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating gadolinium-based MRI contrast (gadobutrol) for depicting delayed enhancement in patients with myocardial infarction; the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Gadovist (gadobutrol)

Snippet

Sponsor: Bayer | Conditions: Myocardial Infarction | Phase 2 | Status: COMPLETED